None listed
Conditions
Brief summary
Smoking is a major cause of death and disease in New Zealand. Nicotine replacement therapy (NRT) is a key aid to stopping smoking, and can be achieved with patches, gum, inhaler, or tablets. In New Zealand only the patch and gum are subsidised. New ways are urgently needed to get more people to use effective NRT to help them quit. The SONIQ trial will investigate whether smokers who have more choice over which NRT delivery methods they use are more likely to have quit smoking at six months, than smokers with current practice (with NRT available only by patch and/or gum). Smokers in the treatment group will try out the four different forms of NRT for a week, before choosing one or two to use for eight weeks.
Interventions
Participants will be randomised to a selection box of NRT or current practice. Telephone counselling and advice will be available to all participants in the usual manner, via Quitline.
Selection box group: Participants will be sent a box containing four different NRT delivery methods, namely patch (21mg), gum (4mg, fruit and mint), inhaler (10mg), and sublingual tablet (2mg), along with a culturally appropriate video/DVD and printed material. Participants will be asked to try out each produc
Participants will be randomised to a selection box of NRT or current practice. Telephone counselling and advice will be available to all participants in the usual manner, via Quitline. Selection box group: Participants will be sent a box containing four different NRT delivery methods, namely patch (21mg), gum (4mg, fruit and mint), inhaler (10mg), and sublingual tablet (2mg), along with a culturally appropriate video/DVD and printed material. Participants will be asked to try out each product over a week prior to their quit attempt. Participants will then be contacted by telephone and asked to choose one or two preferred methods of delivery to use for eight weeks after their Quit day.
Sponsors
Clinical Trials Research Unit, School of Population Health, Auckland University
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Participants will be people from throughout New Zealand who smoke, who contact Quitline (by phone) for smoking cessation advice and assistance. Smokers will be eligible provided they: want to stop smoking within the next two weeks; have their first cigarette within 30 minutes of waking; are able to provide verbal consent; have a telephone.
Exclusion criteria
Pregnant women and women who are breastfeeding will be excluded from the trial. People will also be excluded from the trial if they meet any of the following criteria: current users of NRT products; current users of Zyban (buproprion), clonidine or nortriptyline; use only non-cigarette tobacco products (e.g. pipes, cigars); have had a myocardial infarction within the last three months; and have had unstable or progressive angina pectoris, Prinzmetal’s angina, severe cardiac arrhythmia or a stroke in acute phase.
Outcome results
None listed